High-Sensitivity CRP and LDL-C Predictive of Subsequent MACE in T2D
High sensitivity C-reactive protein levels were associated with recurrent cardiovascular events in patients with T2D and history of recent acute coronary syndrome.
There are no clear benefits or harms to choosing short-acting insulin analogs over regular human insulin for nonpregnant, adult individuals with type 2 diabetes.
Compared with GLP-1 receptor agonists, initiation of canagliflozin use for treatment of type 2 diabetes was not associated with increased risk for fracture.
Patients with T2D who initiated second-line antidiabetic medication therapy demonstrated similar CV risk after starting GLP-1 receptor agonists, SGLT-2 inhibitors, and DPP-4 inhibitors, which was below the threshold of harm.